Mark Cuban Cost Plus Savings Partnering with Penn Medicine
Penn Medicine has teamed up with Mark Cuban's Cost Plus Drug Company through its Cost Plus Marketplace to secure the 100 most frequently dispensed generic drugs—including antibiotics, cancer treatments, blood thinners, and asthma medications—for its retail pharmacy network. Serving 16 locations and filling over 1.5 million prescriptions annually, Penn Medicine is among the first health systems to adopt this transparent pricing model, launched in 2023 and powered by GraphiteRx. This partnership aims to improve access to affordable medications nationwide.
Mark Cuban Cost Plus Savings Partnering with Penn Medicine